BRG Borregaard

Borregaard ASA: Changes in business segments and financial reporting

Borregaard ASA: Changes in business segments and financial reporting

Borregaard has made changes to the Group’s segment reporting and the composition of the business areas in order to better align with value chains in production and internal reporting structures.

All lignin-based products, including biovanillin, have been organised under one management in BioSolutions. The new segment consists of the previous Performance Chemicals and the Ingredients part of Other Businesses.

BioMaterials consist of products utilising wood fibres as the main raw material, and includes the speciality cellulose and cellulose fibrils businesses.

Fine Chemicals includes pharma intermediates (mainly used for diagnostics) and bioethanol (mainly for biofuel).

Corporate overhead and certain other costs that previously have been reported under Other Businesses, have been allocated to the three business segments.

Segment performance, which previously has been measured based on EBITA¹, will primarily be measured based on EBITDA².

Restated figures reflecting the changes for 2015 to 2019 are attached.

1 EBITA is defined by Borregaard as operating profit before amortisation and other income and expenses.

2 EBITDA is defined by Borregaard as operating profit before depreciation, amortisation and other income and expenses.

Contacts:

Director Investor Relations, Jørn Syvertsen,  335

CFO Per Bjarne Lyngstad, CFO,

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Attachment

EN
26/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye
 PRESS RELEASE

Borregaard ASA: EBITDA1 of NOK 511 million in the 1st quarter

Borregaard ASA: EBITDA1 of NOK 511 million in the 1st quarter Borregaard’s operating revenues increased to NOK 2,036 million (NOK 1,975 million)2 in the 1st quarter of 2025. EBITDA1 reached NOK 511 million (NOK 442 million). The result in BioSolutions increased, BioMaterials had a result in line with the corresponding quarter last year and Fine Chemicals had a lower result. Strong sales to agriculture were the main reason for the all-time high result in BioSolutions. For BioMaterials, higher sales prices were offset by lower sales volume, increased wood costs, and cost increases in general...

 PRESS RELEASE

Borregaard ASA: Invitation to Q1 2025 announcement

Borregaard ASA: Invitation to Q1 2025 announcement 23 April 2025: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Presentation of Q1 2025 results Borregaard will report first quarter 2025 results on Wednesday 30 April 2025 at 07:00 CEST. A stock exchange announcement will be made. A press release, the quarterly report and a presentation will be made available on . A presentation of the first quarter 2025 results will also be held at 08:30 CEST at SEB, Filipstadveien 10, Bygg B, Oslo. Attendance in person is possible. The presentation can be followed live on web-TV at . It will be possible...

 PRESS RELEASE

Borregaard ASA: Shares traded ex-dividend today

Borregaard ASA: Shares traded ex-dividend today The shares in Borregaard ASA will be traded ex-dividend of NOK 4.25 per share as from today, 11 April 2025. Borregaard ASASarpsborg, 11 April 2025 Contact:Lotte Kvinlaug, Investor Relations Officer, This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.

 PRESS RELEASE

Borregaard ASA: Issuance of Commercial Paper

Borregaard ASA: Issuance of Commercial Paper Borregaard ASA has issued a commercial paper ISIN NO0013536136 of NOK 200,000,000. Start date: 14 April, 2025Maturity: 14 October, 2025Coupon: 4.89 %Organised by: DNB Markets Sarpsborg, 10 April 2025 Contact:Director Investor Relations, Knut-Harald Bakke, This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch